Clinical, Biochemical, and Radiological Profile of Normocalcemic Primary Hyperparathyroidism
- PMID: 32271382
- DOI: 10.1210/clinem/dgaa174
Clinical, Biochemical, and Radiological Profile of Normocalcemic Primary Hyperparathyroidism
Abstract
Context: The clinical and radiological aspects of normocalcemic hyperparathyroidism (NHPT) are confounded by the differing methods used to rule out secondary hyperparathyroidism and by the small sample size.
Objective: To assess the clinical, biochemical, and radiological profile of NHPT compared with primary hyperparathyroidism (PHPT) and control subjects.
Design: Multicentric cross-sectional study.
Setting: Outpatient clinic.
Patients: 47 NHPT, 41 PHPT, and 39 age- and sex-matched control subjects.
Main outcome measures: Calcium metabolism and bone turnover markers (BTMs). Lumbar spine, total hip, femoral neck, one-third distal radius bone mineral density (BMD). Morphometric vertebral fracture (VF) assessed by dual-energy X-ray absorptiometry.
Results: NHPT patients had significantly higher parathyroid hormone, 25(OH)-vitamin D levels and lower calcium × phosphorus product than controls (P < .001). Compared with PHPT, the NHPT group had significantly higher 25(OH) vitamin D levels (P = .016). NHPT had BTM levels similar to controls and PHPT. NHPT, PHPT, and controls have similar lumbar spine and femoral neck BMD. NHPT and controls had a similar radial BMD, while patients with PHPT had a lower radial BMD than both patients with NHPT (P = .031) and controls (P < .05). Using the control group as the reference, after adjustment for interacting factors, there was no increase in risk of moderate-severe VF in NHPT (odds ratio [OR] 1.04, 95% confidence interval [CI] 0.25-4.55), while PHPT had an increased risk (OR 3.81,95% CI 1.15-15.12). Seventy-nine percent of NHPT and 59% of PHPT patients fulfilled the criteria for asymptomatic hyperparathyroidism.
Conclusions: The biochemical phenotype of NHPT is intermediate between PHPT and controls. In contrast, the bone phenotype resembles controls with normal bone turnover, no significant BMD impairment, and no increased risk of VF.
Keywords: Hyperparathyroidism; PTH; calcium; hypercalcemia; normocalcemic.
© Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Similar articles
-
Bone status in primary hyperparathyroidism assessed by regional bone mineral density from the whole body scan and QUS imaging at calcaneus.Joint Bone Spine. 2006 Jan;73(1):86-94. doi: 10.1016/j.jbspin.2004.08.015. Epub 2005 Apr 16. Joint Bone Spine. 2006. PMID: 15893950
-
The threshold of bone mineral density for vertebral fractures in female patients with primary hyperparathyroidism.Eur J Endocrinol. 2005 Sep;153(3):373-8. doi: 10.1530/eje.1.01985. Eur J Endocrinol. 2005. PMID: 16131599
-
DXA-based bone strain index in normocalcemic primary hyperparathyroidism.Osteoporos Int. 2023 May;34(5):999-1003. doi: 10.1007/s00198-023-06669-y. Epub 2023 Jan 14. Osteoporos Int. 2023. PMID: 36640186
-
Normocalcemic and Normohormonal Primary Hyperparathyroidism: Laboratory Values and End-Organ Effects.Otolaryngol Head Neck Surg. 2021 Sep;165(3):387-397. doi: 10.1177/0194599820983728. Epub 2021 Jan 19. Otolaryngol Head Neck Surg. 2021. PMID: 33461421 Review.
-
Effects of PTH and PTH Hypersecretion on Bone: a Clinical Perspective.Curr Osteoporos Rep. 2020 Jun;18(3):103-114. doi: 10.1007/s11914-020-00574-7. Curr Osteoporos Rep. 2020. PMID: 32222892 Review.
Cited by
-
PTH immunoassay interference: differential diagnosis with normocalcemic primary hyperparathyroidism?Arch Endocrinol Metab. 2024 Nov 6;68:e230315. doi: 10.20945/2359-4292-2023-0315. eCollection 2024. Arch Endocrinol Metab. 2024. PMID: 39529983 Free PMC article.
-
Osteoporosis and Normocalcemic Primary Hyperparathyroidism (Conservatively or Surgically Managed).J Clin Med. 2024 Oct 23;13(21):6325. doi: 10.3390/jcm13216325. J Clin Med. 2024. PMID: 39518465 Free PMC article. Review.
-
Natural history and complications of normocalcemic hyperparathyroidism: a retrospective cohort study.JBMR Plus. 2024 May 31;8(7):ziae074. doi: 10.1093/jbmrpl/ziae074. eCollection 2024 Jul. JBMR Plus. 2024. PMID: 39290342 Free PMC article.
-
Assessment of Vitamin D Status in Primary Hyperparathyroidism Patients: A Retrospective Study.Cureus. 2024 Jul 20;16(7):e64988. doi: 10.7759/cureus.64988. eCollection 2024 Jul. Cureus. 2024. PMID: 39040613 Free PMC article.
-
Genetic aspects underlying the normocalcemic and hypercalcemic phenotypes of primary hyperparathyroidism.Endocrine. 2023 Dec;82(3):646-653. doi: 10.1007/s12020-023-03476-7. Epub 2023 Aug 31. Endocrine. 2023. PMID: 37651007 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
